BRAIN CANCER

This study tested a drug called VAL-083, given alongside standard radiation therapy, for people newly diagnosed with an aggressive brain cancer called glioblastoma (GBM). It focused on patients whose tumors have a specific genetic feature (unmethylated MGMT) that makes them less …

This study tested a new MRI contrast agent called RVP-001, which uses manganese instead of gadolinium, to see if it could safely and effectively detect lesions in the brain and central nervous system. It involved 18 adults with known conditions like brain tumors or multiple scler…

This small, early-stage study tested a new type of combined PET and MRI scan to see if it could take clearer pictures of brain tumors. It involved 5 adult patients with new or suspected returning brain tumors who were already scheduled for treatment. The goal was to gather initia…

This study tested a new brain training program designed to help people who have survived brain cancer but are struggling with memory, thinking, or behavior changes. The program involved both the patient and a family caregiver to help practice new skills at home. Researchers wante…

This study tested a special therapy program designed to help people with advanced brain cancer manage the emotional distress that comes with their diagnosis. Researchers compared the therapy, called CALM, to standard care in 60 patients. The main goal was to see if the program wa…

This study tested whether a digital support program and a dedicated guide could help family caregivers of brain cancer patients feel less stressed, anxious, and burdened. It involved nearly 300 caregivers and their patients. The goal was to see if this support system improved the…

This study aimed to better understand brain and spinal cord tumors by observing over 1,200 adult patients over time. Researchers collected medical information, scans, and tissue samples to learn how these cancers progress and to identify areas for future treatment research. The s…